Relay Therapeutics, Inc. Profile Avatar - Palmy Investing

Relay Therapeutics, Inc.

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indi…

Biotechnology
US, Cambridge [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Relay Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Relay Therapeutics, Inc. can't present revenue by segment

End of RLAY's Analysis
CIK: 1812364 CUSIP: 75943R102 ISIN: US75943R1023 LEI: - UEI: -
Secondary Listings
RLAY has no secondary listings inside our databases.